Stockreport

Moleculin begins NIH-funded Phase II glioblastoma treatment trial [Yahoo! Finance]

Moleculin Biotech, Inc.  (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors
PDF The trial is being conducted under Northwestern University's Investigative New Drug application, which references Moleculin's own US Food and Drug Administration (FDA)- [Read more]